Omada Health director granted 698 RSUs

Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.

Omada Health, Inc. director Julie D. Klapstein received an award of 698 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs were granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees and carry a grant price of $0.00 per share.

Each RSU represents the right to receive one share of Common Stock, with settlement to occur on a date selected by the director or as otherwise provided by the program. Following this compensatory grant, Klapstein’s direct holdings total 10,434 shares of Common Stock reported in this filing.

Insider Trade Summary

Grant/Award: 698 shares

Grant/Award 1 txn

Insider Klapstein Julie D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	698	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,434 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Key Figures

RSUs granted: 698 RSUs Grant price per share: $0.00 per share Shares held after transaction: 10,434 shares +1 more

4 metrics

RSUs granted 698 RSUs Equity award to director on 2026-04-05

Grant price per share $0.00 per share RSU compensation grant, non-cash

Shares held after transaction 10,434 shares Director’s direct holdings following RSU award

Transaction type Grant, award, or other acquisition Reported with code A, non-derivative

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, retainer fees, Common Stock

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

retainer fees financial

"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

Common Stock financial

"Each RSU represents the right to receive one (1) share of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) director Julie Klapstein report in this Form 4?

Julie Klapstein reported receiving 698 restricted stock units (RSUs) of Omada Health Common Stock. These RSUs were granted as part of director compensation, not through an open-market purchase, and increase her reported direct holdings to 10,434 shares after the award.

Is the Omada Health (OMDA) Form 4 transaction a stock purchase or compensation grant?

The Form 4 reflects a compensation grant, not a stock purchase. Director Julie Klapstein received 698 RSUs at a price of $0.00 per share under the Non-Employee Director Compensation Program, issued in lieu of cash retainer fees for board service.

How many Omada Health (OMDA) shares does Julie Klapstein hold after this RSU grant?

After receiving 698 RSUs, Julie Klapstein is reported to hold 10,434 shares of Omada Health Common Stock directly. This total includes the new award and represents her beneficial ownership as disclosed in this Form 4 filing with the SEC.

What are the key terms of the RSUs granted to Omada Health (OMDA) director Julie Klapstein?

Each RSU granted to Julie Klapstein represents the right to receive one share of Omada Health Common Stock. Settlement occurs either on a date she selects under the Non-Employee Director Compensation Program or as otherwise specified by the program’s terms.

Why did Omada Health (OMDA) grant RSUs instead of cash to its director?

The 698 RSUs were granted to Julie Klapstein in lieu of retainer fees under Omada Health’s Non-Employee Director Compensation Program. This structure compensates non-employee directors with equity rather than cash, aligning director compensation with the company’s stock performance over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klapstein Julie D

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/05/2026		A		698(1)	A	$0	10,434	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Julie D. Klapstein	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)